ACS Nano 2015-11-24

Polymer-Grafted Mesoporous Silica Nanoparticles as Ultrasound-Responsive Drug Carriers.

Juan L Paris, M Victoria Cabañas, Miguel Manzano, María Vallet-Regí

Index: ACS Nano 9 , 11023-33, (2015)

Full Text: HTML

Abstract

A new ultrasound-responsive system based on mesoporous silica nanoparticles was developed for biomedical applications, grafting a copolymer on their surface that acts as gatekeeper of the pores. The nanoparticles can be loaded with a cargo at low temperature (4 °C), taking advantage of the open conformation that the polymer presents under these conditions. Then, at 37 °C the copolymer collapses closing the pore entrances and allowing the nanoparticles to carry the drugs at physiological temperature without premature release, which is of great importance when dealing with cytotoxic drugs in cancer treatments. Upon ultrasound irradiation, the sensitive polymer changes its hydrophobicity and, therefore, its conformation toward coil-like opening the gates and releasing the cargo. These hybrid nanoparticles have been shown to be noncytotoxic and can be internalized into LNCaP cells retaining their ultrasound-responsive capability in the cytoplasm of the cells. Moreover, doxorubicin-loaded hybrid MSNs were incubated with LNCaP cells to show their capacity to induce cell death only when the nanoparticles had been exposed to ultrasound. This work demonstrates that our hybrid-MSNs can be triggered by remote stimuli, which is of capital importance for future applications in drug delivery and cancer therapy.


Related Compounds

Related Articles:

Process development for scum to biodiesel conversion.

2015-06-01

[Bioresour. Technol. 185 , 185-93, (2015)]

Biocompatible, biodegradable and porous liquid crystal elastomer scaffolds for spatial cell cultures.

2015-02-01

[Macromol. Biosci. 15(2) , 200-14, (2015)]

Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue.

2015-02-01

[Drug Test. Anal. 7(2) , 131-42, (2015)]

Bioadhesive emulsions for control release of progesterone resistant to vaginal fluids clearance.

2014-12-30

[Int. J. Pharm. 477(1-2) , 495-505, (2014)]

Development of antibodies for determination of alkylresorcinol metabolites in human urine and elucidation of ELISA cross-reactivity.

2014-11-01

[J. Immunol. Methods 413 , 12-24, (2014)]

More Articles...